Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Chinese-made Versus WHO-PQ Praziquantel for Treatment of Schistosoma Haematobium in Zanzibar: a Randomized Controlled Trial

NCT03133832 is registered in ClinicalTrials.gov with Jiangsu Institute of Parasitic Diseases as lead sponsor.

NCT NCT03133832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03133832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Chinese-made Versus WHO-PQ Praziquantel for Treatment of Schistosoma Haematobium in Zanzibar: a Randomized Controlled Trial
Lead sponsor
Jiangsu Institute of Parasitic Diseases
Phase
Phase 3
Overall status
Unknown status
Start date
April 10, 2017
Completion date
July 10, 2017
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schistosomiasis haematobia